Showing results (191-200 of 3,561) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|June 8, 2020
Hyperacute multi-organ thromboembolic storm in COVID-19: a case reportSarah Chibane, Guillaume Gibeau, Frédéric Poulin, et al.Journal of Thrombosis and Thrombolysis|August 9, 2021
MicroRNA-29b reduces myocardial ischemia-reperfusion injury in rats via down-regulating PTEN and activating the Akt/eNOS signaling pathwayKunsheng Li, Pengyu Zhou, Shiliang Li, et al.Journal of Thrombosis and Thrombolysis|August 4, 2021
Safety of apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant gliomaAlissa A Thomas, Heather Wright, Kelly Chan, et al.Journal of Thrombosis and Thrombolysis|August 5, 2021
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesiclesRichard C Becker, Travis Sexton, Susan Smyth, et al.Journal of Thrombosis and Thrombolysis|May 21, 2021
Screening for venous thromboembolism in patients with COVID-19Christophe Vandenbriele, Diana A GorogJournal of Thrombosis and Thrombolysis|August 5, 2021
Overexpression of miR-1298 attenuates myocardial ischemia-reperfusion injury by targeting PP2AChun Ouyang, Lei Huang, Xiaoqiang Ye, et al.Journal of Thrombosis and Thrombolysis|August 6, 1999
Low-molecular-weight heparin should replace unfractionated heparin in the management of acute coronary syndromesP J ZedJournal of Thrombosis and Thrombolysis|August 6, 1999
Clinical implications of elevated PAI-1 revisited: multiple arterial thrombosis in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1 (PAI-1) levels: a case report and review of the literatureS L Senno, L PechetJournal of Thrombosis and Thrombolysis|March 15, 2001
Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatranL Chi, T E Mertz, K L Rogers, et al.Journal of Thrombosis and Thrombolysis|March 15, 2001
Trousseau's syndrome treated with long-term subcutaneous lepirudin (case report and review of the literature)A C Andreescu, M Cushman, J M Hammond, et al.Pageof 357